| Sanofi-Aventis says flu vaccine approved in France | 11/16/2009 - 09:07 |
| Another Vytorin Mess For Merck | 11/16/2009 - 09:06 |
| Bristol-Myers to split off Mead Johnson | 11/16/2009 - 08:49 |
| What Genentech and Roche Got From Congress for $15M | 11/15/2009 - 18:17 |
| Short Blood Supply Means Long Outlook for Cerus | 11/15/2009 - 18:15 |
| FDA Panel to Consider New Flu Vaccine Technology | 11/15/2009 - 18:14 |
| Big Pharma Willing to Pay for Biotech Innovation | 11/15/2009 - 18:11 |
| Vials of 5 Genzyme Drugs for Rare Diseases May Be Contaminated, F.D.A. Says | 11/14/2009 - 13:35 |
| NicOx Reports Positive Data for Cholesterol Drug | 11/14/2009 - 13:34 |
| Drug may slow down Parkinson's, Alzheimer's and Huntington's diseases | 11/14/2009 - 13:16 |
| Endo Pharma to pay US$ 23 mn to LecTec to settle patent litigation | 11/14/2009 - 13:12 |
| Why the FDA Needs to Accept PhRMA's Social Proposal | 11/14/2009 - 13:05 |
| Abbott: Brave or Stupid? | 11/14/2009 - 13:00 |
| Questioning Pfizer's Integrity | 11/14/2009 - 12:58 |
| Lilly Gets R&D Chief From Outside. Drugs to Follow? | 11/14/2009 - 12:52 |
| Spectrum Pharmaceuticals, Inc.: Warming Up or Cooling Off? | 11/14/2009 - 12:51 |
| Merck: Both Sides Now | 11/14/2009 - 12:46 |
| Genzyme Issues Letters to U.S. Healthcare Providers | 11/14/2009 - 12:44 |
| Law Firms Going After Hemispherx | 11/14/2009 - 12:42 |
| Trimeris profit sliced in half | 11/14/2009 - 12:41 |
| Lexicon says IBS drug met mid-stage study goal | 11/14/2009 - 12:37 |
| Gilead Awaits Committee Outcome | 11/13/2009 - 10:38 |
| Another Win for Mylan | 11/13/2009 - 10:36 |
| Options Boil on Biotech Buyout Rumors - Cubist | 11/13/2009 - 09:56 |
| House Bill Wants Pharma To Disclose CME Funding | 11/13/2009 - 09:55 |
| GSK's Witty doesn't anticipate dip in profit margins | 11/13/2009 - 09:54 |
| The Next Vytorin Study: Why Is Everybody So Worked Up? | 11/13/2009 - 09:51 |
| Piper Jaffray Sees Pharma M&A Activity Continuing | 11/13/2009 - 09:50 |
| Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching | 11/13/2009 - 08:54 |
| Myriad Pharma posts smaller 1Q loss after spinoff | 11/13/2009 - 08:40 |
